App 4D and Financial Report Half Year ended 30 Sep 2024
Filed with ASX · · 26 pages · English
Amplia Therapeutics Ltd. on 6ix
Story so far
Earlier from Amplia Therapeutics
- Security Class Suspension from Quotation
- Amplia Successfully Completes Institutional Offer
- Capital Raise Presentation
- Amplia to Raise up to $13m for ACCENT and US Trials
- Interim Data From Accent Pancreatic Cancer Trial
Later from Amplia Therapeutics
- Security Class Reinstatement to Quotation - ATXOA
- Completion of Recruitment of ACCENT Trial
- ACCENT Trial Achieves Superiority over Chemotherapy Alone
- Preliminary Final Report and Annual Report YE 31 March 2025
- Pathological Complete Response in Pancreatic Cancer Trial
Follow Amplia Therapeutics into a list and get an email when it puts out news.
Follow Amplia Therapeutics